Past, present, and future of insulin pump therapy: better shot at diabetes control
- PMID: 18729180
- PMCID: PMC2562271
- DOI: 10.1002/msj.20055
Past, present, and future of insulin pump therapy: better shot at diabetes control
Abstract
With the advent of continuous subcutaneous insulin infusion therapy and the findings of the Diabetes Control and Complications Trial, the management of type 1 diabetes has changed drastically. Over the past 30 years since its development, the effectiveness of continuous subcutaneous insulin infusion has been assessed in comparison with other modes of intensive treatment. Additionally, improvements in pump delivery systems have been made. Here, the findings of the studies on pump therapy are reviewed. Selection criteria of patients for pump use and how to initiate pump therapy are presented. Finally, newer findings on continuous glucose sensors are discussed as the next era of pump therapy continues to focus on the goal of developing an artificial pancreas.
References
-
- Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300:573–578. - PubMed
-
- Home PD, Pickup JC, Keen H, Alberti KG, Parsons JA, Binder C. Continuous Subcutaneous Insulin Infusion: Comparison of Plasma Insulin Profiles After Infusion or Bolus Injection of the Mealtime Dose. Metabolism. 1981;30:439–442. - PubMed
-
- Lauritezen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of Continuous Subcutaneous Insulin Infusion. Diabetologia. 1983;24:326–329. - PubMed
-
- Amiel SA, Tamborlane WV, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin dependent diabetes mellitus. N Engl J Med. 1987;316:1376–1383. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
